Ralph Massullo, MD
MOHS-Micrographic Surgery · Lecanto, FLNPI 1104810563
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (59.6%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. E.r. Squibb & Sons, L.L.C. accounts for 62.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $2,694 and has fallen 92.9% since, to $190 in 2025.
Across 56 payments — averaging $89.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$3K
- Pfizer$1K
- AbbVie$326
- Smith+Nephew$124
- LEO Pharma Inc.$121
- Novartis$76
- plus $262 from 9 others
What the payments were for
- Speaking & faculty fees$1,00020%
- Food & beverage$1,03821%
- Gifts$3,00060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 9 | $3,128 |
| Pfizer | 1 | $1,000 |
| AbbVie(2 entities) | 17 | $326 |
| Smith+Nephew | 7 | $124 |
| LEO Pharma Inc. | 6 | $121 |
| Novartis | 3 | $76 |
| Amgen | 3 | $61 |
| Sensus Healthcare, Inc. | 1 | $54 |
| Johnson & Johnson | 3 | $36 |
| Galderma Laboratories, L.p. | 1 | $27 |
| Lilly USA, LLC | 1 | $21 |
| Sanofi | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Kerecis Limited | 1 | $10 |
How this compares
$5,038 in reported general payments places this provider in the 75th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 662 | $2,279 |
| Mupirocin | 176 | $1,243 |
| Doxycycline Hyclate | 130 | $721 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 19 | $607 |
| Triamcinolone Acetonide | 20 | $138 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Lecanto
- William WeltonLecanto$3K
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.